Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed... see more

TSX:PRN - Post Discussion

Profound Medical Corp > Seeking some alpha news.
View:
Post by Ezzzra on Apr 06, 2020 6:54pm

Seeking some alpha news.

https://seekingalpha.com/article/4335884-profound-medical-apple-of-prostate-arena[/tag]
Comment by MUGMODs on Apr 06, 2020 10:13pm
This post has been removed in accordance with Community Policy
Comment by Ezzzra on Apr 06, 2020 11:33pm
Lol. I should of known you already got the link up and running. I missed that link below your comments. Nice work Mugs. Always one step of the herd.
Comment by MUGMODs on Apr 07, 2020 11:01am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities